K1: Second/third global COVID-19 wave and company's development
Now we will take a look at its mother share K-One Tech.
Fundamentally, the company is in state of
- Market Cap: 222m
- Last traded price: 0.305
- EPS: 0.85 (undervalue)
- ROE: 5.28 (not so good)
- NTA: 0.161 (overvalue but still okay)
- PE Ratio: 35.88 (not so good)
- Financially: since 2018, the company is in positive net profit.
Financial strength:
I found a few interesting fact on K-One
1) The company has a significant amount of cash pile to date. This has enable the company to pivot their business at any time needed and able to sustain good cashflow especially during crisis (i.e. COVID-19)
2) Based on their quarter report, I noticed that the Cloud profitability has increased from time to time. With the recent news, it will obviously gets better. While on manufacturing, it is mostly dominated by healthcare source i.e. nasal swabs and ventilator. The question is, how long can the source from healthcare sustain? We dont know.. but one thing for sure, cloud technology will be there to also support its financial performance.
Let's look at the current news on K-One Tech:
1) January 2019: K-One secures manufacturing agreement with US-based dental flosser. Long story short, opportunity of RM10 mil sales every year.
2) April 2019: K-One looking to the cloud for a pot of gold . K-One Technology Bhd is banking on its newly-acquired cloud computing business (G-Asia Pacific) to shore up its financial performance. Since then, we see a mixture of profit generation from both manufacturing and cloud computing. That's good.
3) April 2020:K-One ventures into ventilator production amid Covid-19 pandemic. The stocks rally like crazy.
4) May 2020: K-One ventures into nasal swab 3D manufacturing for COVID-19 screening. Of course, like any other healthcare sector counter, the rally.
5) May 2020: K-One sets up Singaporean cloud computing unit.
6) June 2020: K1 was selected by NASA as Selected 8 US manufacturers to make new COVID-19 ventilator. To the moon!
- US is currently at the risk of second wave of COVID-19 following Beijing which has re-imposed quarantine due to the emerging number of daily case. After a good pullback, maybe its time to move up again?
Fundamentally, the company is in state of
- Market Cap: 222m
- Last traded price: 0.305
- EPS: 0.85 (undervalue)
- ROE: 5.28 (not so good)
- NTA: 0.161 (overvalue but still okay)
- PE Ratio: 35.88 (not so good)
- Financially: since 2018, the company is in positive net profit.
Financial strength:
I found a few interesting fact on K-One
1) The company has a significant amount of cash pile to date. This has enable the company to pivot their business at any time needed and able to sustain good cashflow especially during crisis (i.e. COVID-19)
2) Based on their quarter report, I noticed that the Cloud profitability has increased from time to time. With the recent news, it will obviously gets better. While on manufacturing, it is mostly dominated by healthcare source i.e. nasal swabs and ventilator. The question is, how long can the source from healthcare sustain? We dont know.. but one thing for sure, cloud technology will be there to also support its financial performance.
Let's look at the current news on K-One Tech:
1) January 2019: K-One secures manufacturing agreement with US-based dental flosser. Long story short, opportunity of RM10 mil sales every year.
2) April 2019: K-One looking to the cloud for a pot of gold . K-One Technology Bhd is banking on its newly-acquired cloud computing business (G-Asia Pacific) to shore up its financial performance. Since then, we see a mixture of profit generation from both manufacturing and cloud computing. That's good.
3) April 2020:K-One ventures into ventilator production amid Covid-19 pandemic. The stocks rally like crazy.
4) May 2020: K-One ventures into nasal swab 3D manufacturing for COVID-19 screening. Of course, like any other healthcare sector counter, the rally.
5) May 2020: K-One sets up Singaporean cloud computing unit.
6) June 2020: K1 was selected by NASA as Selected 8 US manufacturers to make new COVID-19 ventilator. To the moon!
- US is currently at the risk of second wave of COVID-19 following Beijing which has re-imposed quarantine due to the emerging number of daily case. After a good pullback, maybe its time to move up again?
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.